PCI Biotech Holding ASA Asset Resilience Ratio

Latest as of June 2025: 73.51%

PCI Biotech Holding ASA asset resilience ratio. PCI Biotech Holding ASA (PCIB) has an Asset Resilience Ratio of 73.51% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See defensive interval ratio of PCI Biotech Holding ASA to measure how many days the company can operate on defensive assets alone.

Liquid Assets

Nkr13.62 Million

≈ $1.43 Million USD Cash + Short-term Investments

Total Assets

Nkr18.52 Million

≈ $1.95 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio of PCI Biotech Holding ASA (2008–2024)

Asset resilience ratio of PCI Biotech Holding ASA from 2008 to 2024. This chart shows how PCI Biotech Holding ASA's Asset Resilience Ratio has changed over time. Read total liabilities of PCI Biotech Holding ASA for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down PCI Biotech Holding ASA's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see PCIB current and non-current assets.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Nkr13.62 Million	73.51%
Short-term Investments	Nkr0.00	0%
Total Liquid Assets	Nkr13.62 Million	73.51%

Asset Resilience Insights

Very High Liquidity: PCI Biotech Holding ASA maintains exceptional liquid asset reserves at 73.51% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

PCI Biotech Holding ASA Industry Peers by Asset Resilience Ratio

Compare PCI Biotech Holding ASA's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
HLB Co. Ltd KQ:028300	Biotechnology	3.29%
Tubize-Fin BR:TUB	Biotechnology	2.50%
Shanghai Medicilon Inc SHG:688202	Biotechnology	6.69%
Blue Jet Healthcare Limited NSE:BLUEJET	Biotechnology	13.81%
Hangzhou Biotest Biotech Co Ltd SHG:688767	Biotechnology	0.56%
Shouyao Holdings (Beijing) Co. Ltd. A SHG:688197	Biotechnology	79.76%
Shenzhen Weiguang Biological Products Co Ltd SHE:002880	Biotechnology	5.52%

PCI Biotech Holding ASA Asset Resilience Ratio by Year (2008–2024)

PCI Biotech Holding ASA asset resilience ratio by year from 2008 to 2024. The table below shows the annual Asset Resilience Ratio data for PCI Biotech Holding ASA.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	86.72%	Nkr27.07 Million ≈ $2.85 Million	Nkr31.21 Million ≈ $3.28 Million	-6.78pp
2023-12-31	93.49%	Nkr41.18 Million ≈ $4.33 Million	Nkr44.05 Million ≈ $4.64 Million	+4.34pp
2022-12-31	89.15%	Nkr56.60 Million ≈ $5.96 Million	Nkr63.48 Million ≈ $6.68 Million	+3.76pp
2021-12-31	85.39%	Nkr116.12 Million ≈ $12.22 Million	Nkr135.98 Million ≈ $14.31 Million	-4.49pp
2020-12-31	89.88%	Nkr187.97 Million ≈ $19.78 Million	Nkr209.12 Million ≈ $22.01 Million	-2.70pp
2019-12-31	92.58%	Nkr261.10 Million ≈ $27.48 Million	Nkr282.03 Million ≈ $29.68 Million	-5.26pp
2018-12-31	97.84%	Nkr349.33 Million ≈ $36.76 Million	Nkr357.06 Million ≈ $37.57 Million	+10.92pp
2017-12-31	86.91%	Nkr50.79 Million ≈ $5.34 Million	Nkr58.44 Million ≈ $6.15 Million	+24.40pp
2016-12-31	62.51%	Nkr14.00 Million ≈ $1.47 Million	Nkr22.40 Million ≈ $2.36 Million	+61.59pp
2013-12-31	0.93%	Nkr489.00K ≈ $51.46K	Nkr52.74 Million ≈ $5.55 Million	+0.34pp
2012-12-31	0.59%	Nkr463.00K ≈ $48.72K	Nkr78.20 Million ≈ $8.23 Million	+0.24pp
2011-12-31	0.35%	Nkr351.00K ≈ $36.94K	Nkr100.17 Million ≈ $10.54 Million	-91.21pp
2010-12-31	91.56%	Nkr104.88 Million ≈ $11.04 Million	Nkr114.54 Million ≈ $12.05 Million	+10.65pp
2009-12-31	80.91%	Nkr33.60 Million ≈ $3.54 Million	Nkr41.53 Million ≈ $4.37 Million	-7.86pp
2008-12-31	88.77%	Nkr48.45 Million ≈ $5.10 Million	Nkr54.58 Million ≈ $5.74 Million	--

pp = percentage points

About PCI Biotech Holding ASA

OL:PCIB Norway Biotechnology

Market Cap

$274.95K

Nkr2.61 Million NOK

Market Cap Rank

#31280 Global

#275 in Norway

Share Price

Nkr0.07

Change (1 day)

-39.13%

52-Week Range

Nkr0.07 - Nkr0.32

All Time High

Nkr86.30